![Steve Myatt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Steve Myatt
Vorstandsvorsitzender bei Macomics Ltd.
Profil
Steve Myatt is currently the Chief Executive Officer at Macomics Ltd.
He previously worked as the Chief Executive Officer & Director at Azeria Therapeutics Ltd.
Aktive Positionen von Steve Myatt
Unternehmen | Position | Beginn |
---|---|---|
Macomics Ltd.
![]() Macomics Ltd. Miscellaneous Commercial ServicesCommercial Services Macomics Ltd. engages in research and experimental development on biotechnology. The company was founded by Jeffrey William Pollard and Luca Cassetta on November 6, 2018 and is headquartered in Edinburgh, the United Kingdom. | Vorstandsvorsitzender | 01.02.2021 |
Ehemalige bekannte Positionen von Steve Myatt
Unternehmen | Position | Ende |
---|---|---|
Azeria Therapeutics Ltd.
![]() Azeria Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Azeria Therapeutics Ltd. engages in the research and development of pharmaceutical products. It develops treatments for hormone resistance that targets breast and prostate cancer patients. The company was founded by Jason Carroll in 2017 and is headquartered in Cambridge, the United Kingdom. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Azeria Therapeutics Ltd.
![]() Azeria Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Azeria Therapeutics Ltd. engages in the research and development of pharmaceutical products. It develops treatments for hormone resistance that targets breast and prostate cancer patients. The company was founded by Jason Carroll in 2017 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Macomics Ltd.
![]() Macomics Ltd. Miscellaneous Commercial ServicesCommercial Services Macomics Ltd. engages in research and experimental development on biotechnology. The company was founded by Jeffrey William Pollard and Luca Cassetta on November 6, 2018 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |